NCT04988282View on ClinicalTrials.gov

Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

May 24, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
Covid19COVID-19 PneumoniaInterstitial Lung Disease
Interventions
DRUG

Methylprednisolone Tablet

Methylprednisolone, oral, 0.5 mg/kg/day, 4 weeks

Trial Locations (1)

06520

Ufuk University Medicine Faculty, Ankara

All Listed Sponsors
lead

Turkish Thoracic Society

OTHER